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tomography (18F ‑FDG PET/CT) (FIGURE 1A and 1B), 
showing enlarged and metabolically active lymph 
nodes on both sides of the diaphragm, and focal 
lesions in the liver and pituitary gland. This raised 
a suspicion of the lympho‑ or myeloproliferative 
disease or malignancy arising from the gastroin‑
testinal tract. A histological examination of a su‑
praclavicular lymph node revealed metastases of 
adenocarcinoma. Gastroscopy showed neoplastic 
infiltration of the mucosa of the esophagus, cardia, 
and main body of the stomach. A histological ex‑
amination confirmed adenocarcinoma G2. The pa‑
tient was first referred for stereotactic radiothera‑
py of the pituitary tumor. Unfortunately, she died 
a few months later due to cancer dissemination.
Metastases to the sella turcica area and pitu‑
itary gland are rare and represent about 1% of 
A 65 ‑year‑ old woman was admitted to the depart‑
ment of endocrinology due to an abnormal intra‑
sellar and suprasellar mass found a month earli‑
er. A pathological mass (20 × 14 × 16 mm in diam‑
eter) was revealed by magnetic resonance imag‑
ing, which was performed because of a sudden 
onset of diplopia, ptosis of the left palpebra, and 
cranial nerve palsy. On admission, physical exam‑
ination revealed cachexia and paresis of the ocu‑
lomotor (III) and abducens (VI) nerves. Hormon‑
al tests were performed (Supplementary mate‑
rial, Table S1). Because of weight loss of 10 kg in 
the preceding 3 months, tumor markers (CEA, CA 
125, CA 19–9, and CA 15–3) were also measured. 
Owing to a significant elevation of these markers, 
we performed 18F ‑fluorodeoxyglucose positron 
emission tomography integrated with computed 
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FIGURE 1 18F ‑fluorodeoxyglucose positron emission tomography integrated with computed tomography:  
A – enlarged and metabolically active lymph nodes on both sides of the diaphragm (arrow) and focal changes in 
the liver and pituitary gland (arrow); B – a metabolically active pathological mass in the pituitary gland
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all metastases to the brain. Pituitary metasta‑
ses were found in 1.9%1 and 5.1%2 of the patients 
with cancer on autopsy. In the majority of cas‑
es, the primary sites were breast and lung can‑
cers.3 Gastrointestinal tumors constitute 6.4% of 
all pituitary metastases.4 Most of these reports 
were accidental autopsy findings with no symp‑
toms, although about 30% of pituitary metasta‑
ses were the first manifestation of an unknown 
primary tumor, as in our patient.1 
Generally, pituitary metastases are located in 
the posterior lobe, and the most commonly ob‑
served symptom is diabetes insipidus.1,2 Anterior 
hypopituitarism, visual loss, paresis of the cranial 
nerves, or headaches are less frequently reported. 
A rare finding is Cushing syndrome or acromega‑
ly as the result of hyperfunction. Also single cas‑
es of adrenocorticotropic hormone (ACTH)‑de‑
pendent syndrome originating from primary tu‑
mors with ectopic ACTH secretion were report‑
ed.5 Coexisting hyperprolactinemia (prolactin 
>200 ng/ml) is most likely caused by prolactino‑
ma rather than a stalk compression, although Ka‑
lamnos et al2 reported cases where high prolactin 
levels were due to compression,2 as in our case.
Pituitary metastasis can mimic primary be‑
nign pituitary adenoma. He et al1 reported that 
the involvement of the posterior lobe, presence 
of diabetes insipidus or cranial nerve paresis rath‑
er than hypopituitarism, older age, and fast on‑
set of symptoms coexisting with systemic symp‑
toms (weakness, weight loss) can indicate malig‑
nancy. Surgery, radiotherapy, and chemothera‑
py can diminish the size of pituitary metastasis 
and relieves symptoms. However, the outcomes 
are poor. Most patients have distant metasta‑
ses at the time of diagnosis and most of them 
die within a year from diagnosis.1,2,4,5 The main 
aim of the therapy is improvement of the qual‑
ity of life.
SUPPLEMENTARY MATERIAL Supplementa‑
ry material is available with the article at www.
pamw.pl.
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